Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (602)
TREACE MEDICAL CONCEPTS, INC. (TMCI)
Treace John T. — Director
Shares
50,000
Price
$3.56
Total Value
$177.91K
Shares Held After
7,323,833
% of Holdings
0.7%
AUNA S.A. (AUNA)
Zamora Leon Jesus — Director
Shares
6,420
Price
$4.15
Total Value
$26.64K
Shares Held After
69,130
% of Holdings
9.3%
Ascendis Pharma A/S (ASND)
SMITH SCOTT THOMAS — EVP & Chief Financial Officer
Shares
250
Price
$223.32
Total Value
$55.83K
Shares Held After
4,267
% of Holdings
5.9%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
100
Price
$223.50
Total Value
$22.35K
Shares Held After
900
% of Holdings
11.1%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$222.30
Total Value
$44.46K
Shares Held After
800
% of Holdings
25.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$223.76
Total Value
$44.75K
Shares Held After
600
% of Holdings
33.3%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,129
Price
$2.57
Total Value
$5.47K
Shares Held After
9,970
% of Holdings
21.4%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,786
Price
$2.57
Total Value
$4.59K
Shares Held After
17,131
% of Holdings
10.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,829
Price
$2.57
Total Value
$4.70K
Shares Held After
9,840
% of Holdings
18.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,582
Price
$2.57
Total Value
$4.07K
Shares Held After
9,176
% of Holdings
17.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,292
Price
$2.57
Total Value
$5.89K
Shares Held After
10,758
% of Holdings
21.3%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
150
Price
$14.33
Total Value
$2.15K
Shares Held After
2,993
% of Holdings
5.0%
Q32 Bio Inc. (QTTB)
ORBIMED ADVISORS LLC — Director
Shares
625,000
Price
$8.00
Total Value
$5.00M
Shares Held After
625,000
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
ORBIMED ADVISORS LLC — Director
Shares
1,250,000
Price
$8.00
Total Value
$10.00M
Shares Held After
3,502,987
% of Holdings
35.7%
Q32 Bio Inc. (QTTB)
Xu Diyong — Director
Shares
625,000
Price
$8.00
Total Value
$5.00M
Shares Held After
625,000
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
Xu Diyong — Director
Shares
1,250,000
Price
$8.00
Total Value
$10.00M
Shares Held After
3,502,987
% of Holdings
35.7%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Ghiath M. — Director
Shares
8,539,709
Price
$0.59
Total Value
$5.00M
Shares Held After
22,092,068
% of Holdings
38.7%
AUNA S.A. (AUNA)
Zamora Leon Jesus — Director
Shares
9,220
Price
$4.17
Total Value
$38.45K
Shares Held After
55,134
% of Holdings
16.7%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
250
Price
$2.30
Total Value
$575.00
Shares Held After
5,779
% of Holdings
4.3%
WORK Medical Technology Group LTD (WOK)
HRT FINANCIAL LP — 10% Owner
Shares
1,535,850
Price
$0.09
Total Value
$138.23K
Shares Held After
225,234
% of Holdings
681.9%
MYOMO, INC. (MYO)
KIRK THOMAS F — Director
Shares
25,000
Price
$0.99
Total Value
$24.82K
Shares Held After
653,863
% of Holdings
3.8%
Annexon, Inc. (ANNX)
Satter Muneer A — Director
Shares
613,497
Price
$5.41
Total Value
$3.32M
Shares Held After
10,342,134
% of Holdings
5.9%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
48,000
Price
$5.59
Total Value
$268.32K
Shares Held After
3,175,476
% of Holdings
1.5%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
7,115
Price
$5.79
Total Value
$41.20K
Shares Held After
3,127,476
% of Holdings
0.2%
TREACE MEDICAL CONCEPTS, INC. (TMCI)
Treace John T. — Director
Shares
61,202
Price
$3.02
Total Value
$184.82K
Shares Held After
7,273,833
% of Holdings
0.8%
Cencora, Inc. (COR)
DURCAN DERMOT MARK — Director
Shares
4,000
Price
$266.26
Total Value
$1.07M
Shares Held After
27,767
% of Holdings
14.4%
InspireMD, Inc. (NSPR)
Stuka Paul — Director
Shares
20,000
Price
$0.88
Total Value
$17.50K
Shares Held After
667,871
% of Holdings
3.0%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
2,000
Price
$2.00
Total Value
$4.00K
Shares Held After
5,529
% of Holdings
36.2%
AUNA S.A. (AUNA)
Zamora Leon Jesus — Director
Shares
23,273
Price
$4.20
Total Value
$97.70K
Shares Held After
62,710
% of Holdings
37.1%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
4,500
Price
$1.07
Total Value
$4.82K
Shares Held After
62,514
% of Holdings
7.2%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Jerrold B — Director
Shares
6,400
Price
$7.91
Total Value
$50.62K
Shares Held After
520,284
% of Holdings
1.2%
TREACE MEDICAL CONCEPTS, INC. (TMCI)
Treace John T. — Director
Shares
49,810
Price
$2.87
Total Value
$143.19K
Shares Held After
7,212,631
% of Holdings
0.7%
aTYR PHARMA INC (ATYR)
SCHIMMEL PAUL — Director
Shares
100,000
Price
$0.50
Total Value
$49.63K
Shares Held After
779,143
% of Holdings
12.8%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Faisal Ghiath — Director
Shares
122,174
Price
$0.41
Total Value
$50.01K
Shares Held After
125,574
% of Holdings
97.3%
AUNA S.A. (AUNA)
Zamora Leon Jesus — Director
Shares
30,000
Price
$4.39
Total Value
$131.70K
Shares Held After
45,914
% of Holdings
65.3%
AUNA S.A. (AUNA)
Zamora Leon Jesus — Director
Shares
8,727
Price
$4.24
Total Value
$36.99K
Shares Held After
39,437
% of Holdings
22.1%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
23,190
Price
$1.06
Total Value
$24.47K
Shares Held After
58,014
% of Holdings
40.0%
TREACE MEDICAL CONCEPTS, INC. (TMCI)
Treace John T. — Director
Shares
4,508
Price
$2.79
Total Value
$12.58K
Shares Held After
7,162,821
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$18.21
Total Value
$36.42K
Shares Held After
20,000
% of Holdings
10.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$239.37
Total Value
$47.87K
Shares Held After
400
% of Holdings
50.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$236.24
Total Value
$47.25K
Shares Held After
200
% of Holdings
100.0%
Outlook Therapeutics, Inc. (OTLK)
Haddadin Yezan Munther — Director
Shares
34,000
Price
$0.44
Total Value
$14.96K
Shares Held After
37,167
% of Holdings
91.5%
Outlook Therapeutics, Inc. (OTLK)
THURMAN RANDY H — Director
Shares
5,000
Price
$0.43
Total Value
$2.15K
Shares Held After
5,593
% of Holdings
89.4%
Outlook Therapeutics, Inc. (OTLK)
HILZINGER KURT J — Director
Shares
400,000
Price
$0.44
Total Value
$176.52K
Shares Held After
423,655
% of Holdings
94.4%
NewGenIvf Group Ltd (NIVF)
HRT FINANCIAL LP — 10% Owner
Shares
27,993
Price
$0.92
Total Value
$25.75K
Shares Held After
139,878
% of Holdings
20.0%
Hims & Hers Health, Inc. (HIMS)
WELLS DAVID B — Director
Shares
48,400
Price
$24.23
Total Value
$1.17M
Shares Held After
224,417
% of Holdings
21.6%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
5,004
Price
$1.00
Total Value
$5.00K
Shares Held After
126,004
% of Holdings
4.0%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
15,950
Price
$1.05
Total Value
$16.71K
Shares Held After
34,824
% of Holdings
45.8%
HCW Biologics Inc. (HCWB)
Byam Rebecca — Chief Financial Officer
Shares
14,235
Price
$1.41
Total Value
$20.00K
Shares Held After
57,245
% of Holdings
24.9%
HCW Biologics Inc. (HCWB)
GARRETT SCOTT T — Director
Shares
177,936
Price
$1.41
Total Value
$250.00K
Shares Held After
203,441
% of Holdings
87.5%
Showing 1–50 of 602 transactions (page 1 of 13)